As Red Cross moves to pricey blood treatment method, hospitals call for more choice

The American Red Cross will exclusively use an expensive technology to reduce the risk of dangerous bacteria tainting platelets. But the move limits hospitals' choice of less expensive testing options, which are also effective.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...